Inventor · disambiguated record
Christophe Marchand
Also filed as: MARCHAND CHRISTOPHE · MARCHAND CHRISTOPHE R
8 granted patents·4 pending applications·10 citations·filing 2002–2021
78Inventor score
Top patents by PatentIndex Score
12 records- 0187US9399660B2N-substituted indenoisoquinolines and syntheses thereofPURDUE RESEARCH FOUNDATION·Filed 2015·Granted Jul 26, 2016·4 cites·20 claims
- 0273US8716295B2Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1)POMMIER YVES·Filed 2011·Granted May 6, 2014·4 cites·11 claims
- 0372US10906914B2Furoquinolinediones as inhibitors of TDP2AN LINKUN·Filed 2016·Granted Feb 2, 2021·2 cites·17 claims
- 0460US9676771B2Compounds for inhibiting drug-resistant strains of HIV-1 integraseUS HEALTH·Filed 2014·Granted Jun 13, 2017·0 cites·24 claims
- 0559US11999747B2Furoquinolinediones as inhibitors of TDP2THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2021·Granted Jun 4, 2024·0 cites·16 claims
- 0657US2024002445A1Tyrosyl-lock peptidesUS HEALTH·Filed 2021·Application pending·0 cites
- 0755US2009298934A1Diamidine Inhibitors of TDP1US GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 0853US10208035B2Compounds for inhibiting drug-resistant strains of HIV-1 integraseUS HEALTH·Filed 2017·Granted Feb 19, 2019·0 cites·21 claims
- 0952US2010152301A1Treatment of Viral InfectionsUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 1048US8865686B2Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitorsPOMMIER YVES·Filed 2008·Granted Oct 21, 2014·0 cites·8 claims
- 1139US7776883B2Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)US HEALTH·Filed 2005·Granted Aug 17, 2010·0 cites·42 claims
- 1237US2006063938A1Compounds to treat hiv infection and aidsBURKE TERRENCE R·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christophe Marchand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →